USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Pharmaceuticals
-
19 Sep 2018 | North America
Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022
Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics
The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...
$4,950.00 -
24 Apr 2018 | North America
Growth Insights—Real World Evidence Analytics Solutions Market
Innovation and Changing End-user Needs Driving Market Growth
Over the last 3-5 years, growing cost pressure on healthcare and pharmaceutical companies and a significant shift towards outcome based healthcare approach have resulted in companies increasingly adopting real world data and evidence solutions to optimize their operation and cost using analytics. Earlier, applications of RWE were largely limited to...
$3,000.00 -
12 Apr 2018 | Europe
Global Biologics Contract Development & Manufacturing Organization (CDMO) Market—Companies-to-Action
Establishment of Need-based Business Models with Advancements in Manufacturing Techniques is Driving Market Growth
The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...
$3,000.00
